Molecular characterization of methicillin-resistant Staphylococcus aureus nasal isolates from Turkey. 2008

Abdullah Kilic, and Gurkan Mert, and Zeynep Senses, and Orhan Bedir, and Hakan Aydogan, and A Celal Basustaoglu, and Peter C Appelbaum
Department of Microbiology and Clinical Microbiology, Gulhane Military Medical Academy, School of Medicine, 06018, Ankara, Turkey. abkilic@gata.edu.tr

Methicillin-resistant Staphylococcus aureus (MRSA) colonize most frequently in the anterior nares of the nose and cause serious infections all over the world. The aim of this study was to determine the nasal carriage rate of S. aureus and MRSA strains in Turkish elementary school children. We also analyzed molecular characterizations of MRSA strains by using pulse field gel electrophoresis (PFGE), multi locus sequence typing (MLST), staphylococcal chromosomal cassette mec (SCCmec) typing, and detection of the Panton-valentine leucocidin (PVL) gene. The nasal swabs were obtained from 4,050 children during a 4 month period in Ankara. In vitro antimicrobial susceptibility testing to 1 mug oxacillin and 30 mug cefoxitin was determined by a disk diffusion method. We found that the 1,001 of 4,050 (24.7%) children were colonized with S. aureus. Three S. aureus strains were resistant to oxacillin and cefoxitin. The rate of MRSA among all children was 0.07%. The MRSA strains revealed three different PFGE pattern. All MRSA isolates by harbored the SCCmec type IV element, but not the PVL gene. The two MRSA isolate belonged to sequence type (ST) 30, whereas the other one was a unique type. The results of this study demonstrated that S. aureus nasal carriage rate was consistent with previous studies. However, MRSA carriage rate was low. This study also indicated that the ST30-type IV without PVL gene MRSA clone may be expected to spread in Turkish community.

UI MeSH Term Description Entries
D007956 Leukocidins Pore forming proteins originally discovered for toxic activity to LEUKOCYTES. They are EXOTOXINS produced by some pathogenic STAPHYLOCOCCUS and STREPTOCOCCUS that destroy leukocytes by lysis of the cytoplasmic granules and are partially responsible for the pathogenicity of the organisms. Leucocidin,Leukocidin,Leukocidin Proteins,Proteins, Leukocidin
D008297 Male Males
D009666 Nose A part of the upper respiratory tract. It contains the organ of SMELL. The term includes the external nose, the nasal cavity, and the PARANASAL SINUSES. External Nose,External Noses,Nose, External,Noses,Noses, External
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

Abdullah Kilic, and Gurkan Mert, and Zeynep Senses, and Orhan Bedir, and Hakan Aydogan, and A Celal Basustaoglu, and Peter C Appelbaum
July 2014, BMC veterinary research,
Abdullah Kilic, and Gurkan Mert, and Zeynep Senses, and Orhan Bedir, and Hakan Aydogan, and A Celal Basustaoglu, and Peter C Appelbaum
June 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Abdullah Kilic, and Gurkan Mert, and Zeynep Senses, and Orhan Bedir, and Hakan Aydogan, and A Celal Basustaoglu, and Peter C Appelbaum
January 2015, Journal of infection and public health,
Abdullah Kilic, and Gurkan Mert, and Zeynep Senses, and Orhan Bedir, and Hakan Aydogan, and A Celal Basustaoglu, and Peter C Appelbaum
February 2006, The Journal of antimicrobial chemotherapy,
Abdullah Kilic, and Gurkan Mert, and Zeynep Senses, and Orhan Bedir, and Hakan Aydogan, and A Celal Basustaoglu, and Peter C Appelbaum
July 2021, Nigerian journal of clinical practice,
Abdullah Kilic, and Gurkan Mert, and Zeynep Senses, and Orhan Bedir, and Hakan Aydogan, and A Celal Basustaoglu, and Peter C Appelbaum
May 2011, Journal of clinical microbiology,
Abdullah Kilic, and Gurkan Mert, and Zeynep Senses, and Orhan Bedir, and Hakan Aydogan, and A Celal Basustaoglu, and Peter C Appelbaum
December 2011, Pathologie-biologie,
Abdullah Kilic, and Gurkan Mert, and Zeynep Senses, and Orhan Bedir, and Hakan Aydogan, and A Celal Basustaoglu, and Peter C Appelbaum
February 2004, Journal of clinical microbiology,
Abdullah Kilic, and Gurkan Mert, and Zeynep Senses, and Orhan Bedir, and Hakan Aydogan, and A Celal Basustaoglu, and Peter C Appelbaum
October 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Abdullah Kilic, and Gurkan Mert, and Zeynep Senses, and Orhan Bedir, and Hakan Aydogan, and A Celal Basustaoglu, and Peter C Appelbaum
October 2012, Journal of clinical microbiology,
Copied contents to your clipboard!